Hemophilia B acquired after cadaveric liver transplantation: a case report

J Surg Case Rep. 2022 Sep 5;2022(9):rjac393. doi: 10.1093/jscr/rjac393. eCollection 2022 Sep.

Abstract

Hemophilia B is a recessive hereditary disease, and manifestations result from coagulation factor IX deficiency. Although improbable, as factor IX is produced exclusively in the liver, the possibility of developing the disease after transplantation represents an infrequent but potentially morbid complication. Standard laboratory tests may be insufficient to determine the probability of transmission of this pathology. This report describes the case of a patient who developed hemophilia B after liver transplantation whose donor had no prior knowledge of the disease.

Publication types

  • Case Reports